Cookie usage policy

The website of the University Carlos III of Madrid use its own cookies and third-party cookies to improve our services by analyzing their browsing habits. By continuing navigation, we understand that it accepts our cookie policy. "Usage rules"

Comentarios de antiguos alumnos

Comentarios de antiguos alumnos

José Luis López Belmonte

Juan Luis López Belmonte
Market Access Lead, Sanofi

“Comenzamos a ver la luz al final del maravilloso túnel que hemos recorrido este año 2021-2022 con el Mater de Evaluación Sanitaria y Acceso al Mercado de la UC3M, la verdad que no puedo estar más agradecido y contento con la ampliación de conocimientos que he ido adquiriendo en estos meses. En mi departamento no paro de indicar que es un “must do” para todo aquel que quiera de verdad dedicarse al área de acceso al mercado, incluso para aquellos llevamos más de 15 años dentro de este mundo”.

Comments Alumni

Leonardo Ruíz Casas
Global Access market manager. Laboratorios Almirall

    "It's a course that seeks to form a type of very specific and very professional needed within the health sector. I honestly think we were very lucky to be the first class and have completed the master was an important step in our careers. "

Cristina Antón
Market Access Manager, Adelphi

    "Having completed the Master was key for me to get the job I have. Thank you."

Maria José Calvo Alcántara
Division Chief, Procurement Branch Pharmacy and Health Products, Servicio Madrileño de Salud

  "Efficiency, budgetary impact, health outcomes research ... a very intense year, it definitely worth"

Celia Muñoz Fernández. Student of the second edition
Researcher at the Center for Research in Economics and Health (CRES) at the Universidad Pompeu Fabra

   "Being able to attend presentations by reference persons in our country is something that gives quality to this degree. Undoubtedly, it is the kind of training that makes the difference when it comes to getting a job in the health-research sector. "


Ana Mª Murillo. Student of third edition
Communications Officer and Market Access.
PORIB (Pharmacoeconomics & Outcomes Research Iberia)"

  "I am very pleased with my time in the Masters, grateful for the training and professional opportunity that gave me and allowed me to join the team PORIB (Pharmacoeconomics & Outcomes Research Iberia)".

Carlos Betancur Gálvez. Student of fourth edition
Researcher at the Universidad Carlos III de Madrid.

  "The drug-sector economy is having an accelerated growth, since it is necessary to assess all therapeutic to invest adequately the increasingly scarce resources of public health alternatives. The Master has given me the necessary measures to carry out these assessments and to offer my services in a sector that is increasingly demanding more and better professional "tools.